401k Plan data: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST plan

WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 401k Plan overview

Plan Name	WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST
Plan identification number	001

WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

WESTERN NEPHROLOGY AND METABOLIC BONE DISEASE, P.C. has sponsored the creation of one or more 401k plans.

Company Name: WESTERN NEPHROLOGY AND METABOLIC BONE DISEASE, P.C.

Employer identification number (EIN): 841460205

NAIC Classification: 621111
NAIC Description: Offices of Physicians (except Mental Health Specialists)

Form 5500 Filing Information

Submission information for form 5500 for 401k plan WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 CHERMAINE SHEYKO
001 2016-01-01 CHERMAINE SHEYKO CHERMAINE SHEYKO 2017-09-28
001 2015-01-01 KEN QUALMAN
001 2014-01-01 KEN QUALMAN
001 2013-01-01 BEV LONG
001 2012-01-01 BEV LONG
001 2011-01-01 BEV LONG 2012-10-12 BEV LONG 2012-10-11
001 2010-01-01 BAXTER BURTON 2011-10-17

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01
001	2021-01-01
001	2020-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	CHERMAINE SHEYKO
001	2016-01-01	CHERMAINE SHEYKO		CHERMAINE SHEYKO	2017-09-28
001	2015-01-01	KEN QUALMAN
001	2014-01-01	KEN QUALMAN
001	2013-01-01	BEV LONG
001	2012-01-01	BEV LONG
001	2011-01-01	BEV LONG	2012-10-12	BEV LONG	2012-10-11
001	2010-01-01	BAXTER BURTON	2011-10-17

Plan Statistics for WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST

401k plan membership statisitcs for WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST

Measure Date Value
2022: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2022 401k membership
Total participants, beginning-of-year 2022-01-01 256
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 87
Number of retired or separated participants receiving benefits 2022-01-01 2
Number of other retired or separated participants entitled to future benefits 2022-01-01 175
Total of all active and inactive participants 2022-01-01 264
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 264
Number of participants with account balances 2022-01-01 249
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 28
2021: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2021 401k membership
Total participants, beginning-of-year 2021-01-01 246
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 83
Number of retired or separated participants receiving benefits 2021-01-01 3
Number of other retired or separated participants entitled to future benefits 2021-01-01 163
Total of all active and inactive participants 2021-01-01 249
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 249
Number of participants with account balances 2021-01-01 241
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 30
2020: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2020 401k membership
Total participants, beginning-of-year 2020-01-01 230
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 93
Number of retired or separated participants receiving benefits 2020-01-01 7
Number of other retired or separated participants entitled to future benefits 2020-01-01 146
Total of all active and inactive participants 2020-01-01 246
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 246
Number of participants with account balances 2020-01-01 246
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 14
2019: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2019 401k membership
Total participants, beginning-of-year 2019-01-01 218
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 94
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 131
Total of all active and inactive participants 2019-01-01 225
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 225
Number of participants with account balances 2019-01-01 218
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 19
2018: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2018 401k membership
Total participants, beginning-of-year 2018-01-01 254
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 95
Number of retired or separated participants receiving benefits 2018-01-01 3
Number of other retired or separated participants entitled to future benefits 2018-01-01 104
Total of all active and inactive participants 2018-01-01 202
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 202
Number of participants with account balances 2018-01-01 193
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 9
2017: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2017 401k membership
Total participants, beginning-of-year 2017-01-01 98
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 168
Number of retired or separated participants receiving benefits 2017-01-01 4
Number of other retired or separated participants entitled to future benefits 2017-01-01 82
Total of all active and inactive participants 2017-01-01 254
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 254
Number of participants with account balances 2017-01-01 176
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 9
2016: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2016 401k membership
Total participants, beginning-of-year 2016-01-01 145
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 96
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 57
Total of all active and inactive participants 2016-01-01 153
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 1
Total participants 2016-01-01 154
Number of participants with account balances 2016-01-01 142
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 5
2015: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2015 401k membership
Total participants, beginning-of-year 2015-01-01 152
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 92
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 52
Total of all active and inactive participants 2015-01-01 144
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 1
Total participants 2015-01-01 145
Number of participants with account balances 2015-01-01 140
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 2
2014: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2014 401k membership
Total participants, beginning-of-year 2014-01-01 137
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 98
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 53
Total of all active and inactive participants 2014-01-01 151
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 1
Total participants 2014-01-01 152
Number of participants with account balances 2014-01-01 142
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 13
2013: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2013 401k membership
Total participants, beginning-of-year 2013-01-01 133
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 98
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 39
Total of all active and inactive participants 2013-01-01 137
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 137
Number of participants with account balances 2013-01-01 131
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 12
2012: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2012 401k membership
Total participants, beginning-of-year 2012-01-01 123
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 95
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 38
Total of all active and inactive participants 2012-01-01 133
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 133
Number of participants with account balances 2012-01-01 118
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 10

Measure	Date	Value
2022: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2022 401k membership
Total participants, beginning-of-year	2022-01-01	256
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	87
Number of retired or separated participants receiving benefits	2022-01-01	2
Number of other retired or separated participants entitled to future benefits	2022-01-01	175
Total of all active and inactive participants	2022-01-01	264
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	264
Number of participants with account balances	2022-01-01	249
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	28
2021: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2021 401k membership
Total participants, beginning-of-year	2021-01-01	246
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	83
Number of retired or separated participants receiving benefits	2021-01-01	3
Number of other retired or separated participants entitled to future benefits	2021-01-01	163
Total of all active and inactive participants	2021-01-01	249
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	249
Number of participants with account balances	2021-01-01	241
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	30
2020: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2020 401k membership
Total participants, beginning-of-year	2020-01-01	230
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	93
Number of retired or separated participants receiving benefits	2020-01-01	7
Number of other retired or separated participants entitled to future benefits	2020-01-01	146
Total of all active and inactive participants	2020-01-01	246
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	246
Number of participants with account balances	2020-01-01	246
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	14
2019: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2019 401k membership
Total participants, beginning-of-year	2019-01-01	218
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	94
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	131
Total of all active and inactive participants	2019-01-01	225
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	225
Number of participants with account balances	2019-01-01	218
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	19
2018: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2018 401k membership
Total participants, beginning-of-year	2018-01-01	254
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	95
Number of retired or separated participants receiving benefits	2018-01-01	3
Number of other retired or separated participants entitled to future benefits	2018-01-01	104
Total of all active and inactive participants	2018-01-01	202
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	202
Number of participants with account balances	2018-01-01	193
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	9
2017: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2017 401k membership
Total participants, beginning-of-year	2017-01-01	98
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	168
Number of retired or separated participants receiving benefits	2017-01-01	4
Number of other retired or separated participants entitled to future benefits	2017-01-01	82
Total of all active and inactive participants	2017-01-01	254
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	254
Number of participants with account balances	2017-01-01	176
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	9
2016: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2016 401k membership
Total participants, beginning-of-year	2016-01-01	145
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	96
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	57
Total of all active and inactive participants	2016-01-01	153
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	1
Total participants	2016-01-01	154
Number of participants with account balances	2016-01-01	142
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	5
2015: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2015 401k membership
Total participants, beginning-of-year	2015-01-01	152
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	92
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	52
Total of all active and inactive participants	2015-01-01	144
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	1
Total participants	2015-01-01	145
Number of participants with account balances	2015-01-01	140
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	2
2014: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2014 401k membership
Total participants, beginning-of-year	2014-01-01	137
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	98
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	53
Total of all active and inactive participants	2014-01-01	151
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	1
Total participants	2014-01-01	152
Number of participants with account balances	2014-01-01	142
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	13
2013: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2013 401k membership
Total participants, beginning-of-year	2013-01-01	133
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	98
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	39
Total of all active and inactive participants	2013-01-01	137
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	137
Number of participants with account balances	2013-01-01	131
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	12
2012: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2012 401k membership
Total participants, beginning-of-year	2012-01-01	123
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	95
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	38
Total of all active and inactive participants	2012-01-01	133
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	133
Number of participants with account balances	2012-01-01	118
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	10

Financial Data on WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST

Measure	Date	Value
2022 : WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2022 401k financial data
Unrealized appreciation/depreciation of real estate assets	2022-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2022-12-31	$0
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Expenses. Interest paid	2022-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$-2,837,302
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$1,011,467
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$937,142
Expenses. Certain deemed distributions of participant loans	2022-12-31	$0
Value of total corrective distributions	2022-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$1,855,368
Value of total assets at end of year	2022-12-31	$24,756,026
Value of total assets at beginning of year	2022-12-31	$28,604,795
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$74,325
Total income from rents	2022-12-31	$0
Total interest from all sources	2022-12-31	$2,002
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$865,935
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$865,935
Assets. Real estate other than employer real property at end of year	2022-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2022-12-31	$0
Administrative expenses professional fees incurred	2022-12-31	$923
Assets. Corporate prefeered stocks other than exployer securities at end of year	2022-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2022-12-31	$0
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$792,301
Participant contributions at end of year	2022-12-31	$66,773
Participant contributions at beginning of year	2022-12-31	$31,935
Participant contributions at end of year	2022-12-31	$0
Participant contributions at beginning of year	2022-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2022-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2022-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$594,367
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2022-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2022-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2022-12-31	$0
Assets. Loans (other than to participants) at end of year	2022-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2022-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2022-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2022-12-31	$0
Other income not declared elsewhere	2022-12-31	$0
Administrative expenses (other) incurred	2022-12-31	$0
Total non interest bearing cash at end of year	2022-12-31	$0
Total non interest bearing cash at beginning of year	2022-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Income. Non cash contributions	2022-12-31	$0
Value of net income/loss	2022-12-31	$-3,848,769
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$24,756,026
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$28,604,795
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Assets. partnership/joint venture interests at end of year	2022-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2022-12-31	$0
Investment advisory and management fees	2022-12-31	$41,369
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$23,359,767
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$28,572,860
Interest on participant loans	2022-12-31	$2,002
Income. Interest from loans (other than to participants)	2022-12-31	$0
Interest earned on other investments	2022-12-31	$0
Income. Interest from US Government securities	2022-12-31	$0
Income. Interest from corporate debt instruments	2022-12-31	$0
Value of interest in master investment trust accounts at end of year	2022-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2022-12-31	$0
Value of interest in common/collective trusts at end of year	2022-12-31	$1,329,486
Value of interest in common/collective trusts at beginning of year	2022-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2022-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2022-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2022-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2022-12-31	$0
Assets. Value of investments in 103.12 investment entities at end of year	2022-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2022-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2022-12-31	$0
Asset value of US Government securities at end of year	2022-12-31	$0
Asset value of US Government securities at beginning of year	2022-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-5,645,821
Net investment gain/loss from pooled separate accounts	2022-12-31	$0
Net investment gain or loss from common/collective trusts	2022-12-31	$85,214
Net gain/loss from 103.12 investment entities	2022-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Assets. Invements in employer securities at end of year	2022-12-31	$0
Assets. Invements in employer securities at beginning of year	2022-12-31	$0
Assets. Value of employer real property at end of year	2022-12-31	$0
Assets. Value of employer real property at beginning of year	2022-12-31	$0
Contributions received in cash from employer	2022-12-31	$468,700
Employer contributions (assets) at end of year	2022-12-31	$0
Employer contributions (assets) at beginning of year	2022-12-31	$0
Income. Dividends from preferred stock	2022-12-31	$0
Income. Dividends from common stock	2022-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$937,142
Asset. Corporate debt instrument preferred debt at end of year	2022-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2022-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2022-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2022-12-31	$0
Contract administrator fees	2022-12-31	$32,033
Assets. Corporate common stocks other than exployer securities at end of year	2022-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2022-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2022-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2022-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2022-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2022-12-31	$0
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Aggregate proceeds on sale of assets	2022-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2022-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2022-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2022-12-31	$0
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	BROCK AND COMPANY CPAS PC
Accountancy firm EIN	2022-12-31	840930288
2021 : WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2021 401k financial data
Unrealized appreciation/depreciation of real estate assets	2021-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2021-12-31	$0
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Expenses. Interest paid	2021-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$4,880,975
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$1,227,890
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$1,137,226
Expenses. Certain deemed distributions of participant loans	2021-12-31	$14,850
Value of total corrective distributions	2021-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$825,953
Value of total assets at end of year	2021-12-31	$28,604,795
Value of total assets at beginning of year	2021-12-31	$24,951,710
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$75,814
Total income from rents	2021-12-31	$0
Total interest from all sources	2021-12-31	$4,003
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$1,298,949
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$1,298,949
Assets. Real estate other than employer real property at end of year	2021-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2021-12-31	$0
Administrative expenses professional fees incurred	2021-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2021-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2021-12-31	$0
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$766,077
Participant contributions at end of year	2021-12-31	$31,935
Participant contributions at beginning of year	2021-12-31	$66,310
Participant contributions at end of year	2021-12-31	$0
Participant contributions at beginning of year	2021-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2021-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2021-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$52,145
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2021-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2021-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2021-12-31	$0
Assets. Loans (other than to participants) at end of year	2021-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2021-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2021-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2021-12-31	$0
Other income not declared elsewhere	2021-12-31	$0
Administrative expenses (other) incurred	2021-12-31	$0
Total non interest bearing cash at end of year	2021-12-31	$0
Total non interest bearing cash at beginning of year	2021-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Income. Non cash contributions	2021-12-31	$0
Value of net income/loss	2021-12-31	$3,653,085
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$28,604,795
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$24,951,710
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Assets. partnership/joint venture interests at end of year	2021-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2021-12-31	$0
Investment advisory and management fees	2021-12-31	$34,119
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$28,572,860
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$24,375,620
Interest on participant loans	2021-12-31	$4,003
Income. Interest from loans (other than to participants)	2021-12-31	$0
Interest earned on other investments	2021-12-31	$0
Income. Interest from US Government securities	2021-12-31	$0
Income. Interest from corporate debt instruments	2021-12-31	$0
Value of interest in master investment trust accounts at end of year	2021-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2021-12-31	$0
Value of interest in common/collective trusts at end of year	2021-12-31	$0
Value of interest in common/collective trusts at beginning of year	2021-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2021-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2021-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2021-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2021-12-31	$0
Assets. Value of investments in 103.12 investment entities at end of year	2021-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2021-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2021-12-31	$0
Asset value of US Government securities at end of year	2021-12-31	$0
Asset value of US Government securities at beginning of year	2021-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$2,752,070
Net investment gain/loss from pooled separate accounts	2021-12-31	$0
Net investment gain or loss from common/collective trusts	2021-12-31	$0
Net gain/loss from 103.12 investment entities	2021-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Assets. Invements in employer securities at end of year	2021-12-31	$0
Assets. Invements in employer securities at beginning of year	2021-12-31	$0
Assets. Value of employer real property at end of year	2021-12-31	$0
Assets. Value of employer real property at beginning of year	2021-12-31	$0
Contributions received in cash from employer	2021-12-31	$7,731
Employer contributions (assets) at end of year	2021-12-31	$0
Employer contributions (assets) at beginning of year	2021-12-31	$509,780
Income. Dividends from preferred stock	2021-12-31	$0
Income. Dividends from common stock	2021-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$1,137,226
Asset. Corporate debt instrument preferred debt at end of year	2021-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2021-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2021-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2021-12-31	$0
Contract administrator fees	2021-12-31	$41,695
Assets. Corporate common stocks other than exployer securities at end of year	2021-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2021-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2021-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2021-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2021-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2021-12-31	$0
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Aggregate proceeds on sale of assets	2021-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2021-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2021-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2021-12-31	$0
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	BROCK AND COMPANY CPAS P.C.
Accountancy firm EIN	2021-12-31	840930288
2020 : WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$4,141,562
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$1,380,324
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$1,312,978
Expenses. Certain deemed distributions of participant loans	2020-12-31	$3,047
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$1,313,343
Value of total assets at end of year	2020-12-31	$24,951,710
Value of total assets at beginning of year	2020-12-31	$22,190,472
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$64,299
Total interest from all sources	2020-12-31	$6,007
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$840,281
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$840,281
Administrative expenses professional fees incurred	2020-12-31	$6,940
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$803,563
Participant contributions at end of year	2020-12-31	$66,310
Participant contributions at beginning of year	2020-12-31	$109,695
Other income not declared elsewhere	2020-12-31	$4,409
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$2,761,238
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$24,951,710
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$22,190,472
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Investment advisory and management fees	2020-12-31	$24,917
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$24,375,620
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$21,581,708
Interest on participant loans	2020-12-31	$6,007
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$1,977,522
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$509,780
Employer contributions (assets) at end of year	2020-12-31	$509,780
Employer contributions (assets) at beginning of year	2020-12-31	$499,069
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$1,312,978
Contract administrator fees	2020-12-31	$32,442
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Unqualified
Accountancy firm name	2020-12-31	BROCK AND COMPANY CPAS P.C.
Accountancy firm EIN	2020-12-31	840930288
2019 : WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$5,239,400
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$2,650,902
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$2,585,630
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$1,288,728
Value of total assets at end of year	2019-12-31	$22,190,472
Value of total assets at beginning of year	2019-12-31	$19,601,974
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$65,272
Total interest from all sources	2019-12-31	$6,106
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$933,142
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$933,142
Administrative expenses professional fees incurred	2019-12-31	$8,118
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$758,971
Participant contributions at end of year	2019-12-31	$109,695
Participant contributions at beginning of year	2019-12-31	$97,015
Participant contributions at end of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$227
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$30,843
Other income not declared elsewhere	2019-12-31	$4,236
Administrative expenses (other) incurred	2019-12-31	$22,387
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$2,588,498
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$22,190,472
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$19,601,974
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Investment advisory and management fees	2019-12-31	$28,137
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$21,581,708
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$19,039,173
Interest on participant loans	2019-12-31	$6,106
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$3,007,188
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$498,914
Employer contributions (assets) at end of year	2019-12-31	$499,069
Employer contributions (assets) at beginning of year	2019-12-31	$465,559
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$2,585,630
Contract administrator fees	2019-12-31	$6,630
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	BROCK AND COMPANY CPAS P.C.
Accountancy firm EIN	2019-12-31	840930288
2018 : WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$192,432
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$2,359,659
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$2,294,056
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$1,186,212
Value of total assets at end of year	2018-12-31	$19,601,974
Value of total assets at beginning of year	2018-12-31	$21,769,201
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$65,603
Total interest from all sources	2018-12-31	$7,078
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$1,063,466
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$1,063,466
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$717,877
Participant contributions at end of year	2018-12-31	$97,015
Participant contributions at beginning of year	2018-12-31	$170,319
Participant contributions at end of year	2018-12-31	$227
Participant contributions at beginning of year	2018-12-31	$227
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$2,776
Other income not declared elsewhere	2018-12-31	$32,591
Administrative expenses (other) incurred	2018-12-31	$46,474
Total non interest bearing cash at end of year	2018-12-31	$0
Total non interest bearing cash at beginning of year	2018-12-31	$156
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-2,167,227
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$19,601,974
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$21,769,201
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Investment advisory and management fees	2018-12-31	$12,869
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$19,039,173
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$21,160,244
Interest on participant loans	2018-12-31	$7,078
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-2,096,915
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$465,559
Employer contributions (assets) at end of year	2018-12-31	$465,559
Employer contributions (assets) at beginning of year	2018-12-31	$438,255
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$2,294,056
Contract administrator fees	2018-12-31	$6,260
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	No
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	BROCK AND COMPANY CPAS P.C.
Accountancy firm EIN	2018-12-31	840930288
2017 : WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$4,092,721
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$463,730
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$424,319
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$1,270,684
Value of total assets at end of year	2017-12-31	$21,769,201
Value of total assets at beginning of year	2017-12-31	$18,140,210
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$39,411
Total interest from all sources	2017-12-31	$8,944
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$840,486
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$840,486
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$500,000
If this is an individual account plan, was there a blackout period	2017-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$691,105
Participant contributions at end of year	2017-12-31	$170,319
Participant contributions at beginning of year	2017-12-31	$113,896
Participant contributions at end of year	2017-12-31	$227
Participant contributions at beginning of year	2017-12-31	$15,937
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$141,324
Other income not declared elsewhere	2017-12-31	$-31,313
Administrative expenses (other) incurred	2017-12-31	$36,948
Total non interest bearing cash at end of year	2017-12-31	$156
Total non interest bearing cash at beginning of year	2017-12-31	$745
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$3,628,991
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$21,769,201
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$18,140,210
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Investment advisory and management fees	2017-12-31	$13
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$21,160,244
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$13,652,165
Interest on participant loans	2017-12-31	$6,313
Value of interest in common/collective trusts at end of year	2017-12-31	$0
Value of interest in common/collective trusts at beginning of year	2017-12-31	$2,962,788
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2017-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2017-12-31	$451,253
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2017-12-31	$451,253
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2017-12-31	$2,631
Asset value of US Government securities at end of year	2017-12-31	$0
Asset value of US Government securities at beginning of year	2017-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$1,883,761
Net investment gain or loss from common/collective trusts	2017-12-31	$120,159
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$438,255
Employer contributions (assets) at end of year	2017-12-31	$438,255
Employer contributions (assets) at beginning of year	2017-12-31	$943,426
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$424,319
Contract administrator fees	2017-12-31	$2,450
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2017-12-31	Yes
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	BROCK AND COMPANY CPAS P.C.
Accountancy firm EIN	2017-12-31	840930288
2016 : WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$2,926,920
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$1,091,023
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$1,042,340
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$1,615,465
Value of total assets at end of year	2016-12-31	$18,140,210
Value of total assets at beginning of year	2016-12-31	$16,304,313
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$48,683
Total interest from all sources	2016-12-31	$6,392
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$561,626
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$561,626
Administrative expenses professional fees incurred	2016-12-31	$48,683
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$672,908
Participant contributions at end of year	2016-12-31	$113,896
Participant contributions at beginning of year	2016-12-31	$69,394
Participant contributions at end of year	2016-12-31	$15,937
Participant contributions at beginning of year	2016-12-31	$10,718
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2016-12-31	$20,221
Other income not declared elsewhere	2016-12-31	$1,977
Total non interest bearing cash at end of year	2016-12-31	$745
Total non interest bearing cash at beginning of year	2016-12-31	$1,776
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$1,835,897
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$18,140,210
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$16,304,313
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$13,652,165
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$12,141,331
Interest on participant loans	2016-12-31	$5,241
Value of interest in common/collective trusts at end of year	2016-12-31	$2,962,788
Value of interest in common/collective trusts at beginning of year	2016-12-31	$2,647,887
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2016-12-31	$451,253
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2016-12-31	$497,301
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2016-12-31	$497,301
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2016-12-31	$1,151
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$545,246
Net investment gain or loss from common/collective trusts	2016-12-31	$196,214
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$942,557
Employer contributions (assets) at end of year	2016-12-31	$943,426
Employer contributions (assets) at beginning of year	2016-12-31	$915,685
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$1,042,340
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	BROCK AND COMPANY CPAS P.C.
Accountancy firm EIN	2016-12-31	840930288
2015 : WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$39,556
Total income from all sources (including contributions)	2015-12-31	$1,460,629
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$1,066,583
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$1,022,248
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$1,597,764
Value of total assets at end of year	2015-12-31	$16,304,313
Value of total assets at beginning of year	2015-12-31	$15,949,823
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$44,335
Total interest from all sources	2015-12-31	$3,910
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$666,506
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$666,506
Administrative expenses professional fees incurred	2015-12-31	$44,335
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$658,007
Participant contributions at end of year	2015-12-31	$69,394
Participant contributions at beginning of year	2015-12-31	$82,208
Participant contributions at end of year	2015-12-31	$10,718
Participant contributions at beginning of year	2015-12-31	$9,988
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$24,072
Value of other receiveables (less allowance for doubtful accounts) at end of year	2015-12-31	$20,221
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2015-12-31	$39,556
Other income not declared elsewhere	2015-12-31	$6,080
Total non interest bearing cash at end of year	2015-12-31	$1,776
Total non interest bearing cash at beginning of year	2015-12-31	$40,170
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$394,046
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$16,304,313
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$15,910,267
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$12,141,331
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$12,172,025
Interest on participant loans	2015-12-31	$3,910
Value of interest in common/collective trusts at end of year	2015-12-31	$2,647,887
Value of interest in common/collective trusts at beginning of year	2015-12-31	$2,157,427
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2015-12-31	$497,301
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2015-12-31	$664,242
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2015-12-31	$664,242
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-813,631
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$915,685
Employer contributions (assets) at end of year	2015-12-31	$915,685
Employer contributions (assets) at beginning of year	2015-12-31	$823,763
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$1,022,248
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	BROCK AND COMPANY CPAS P.C.
Accountancy firm EIN	2015-12-31	840930288
2014 : WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$39,556
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$2,286,545
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$918,414
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$877,084
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$1,456,520
Value of total assets at end of year	2014-12-31	$15,949,823
Value of total assets at beginning of year	2014-12-31	$14,542,136
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$41,330
Total interest from all sources	2014-12-31	$5,399
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$942,246
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$942,246
Administrative expenses professional fees incurred	2014-12-31	$41,330
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$629,975
Participant contributions at end of year	2014-12-31	$82,208
Participant contributions at beginning of year	2014-12-31	$114,873
Participant contributions at end of year	2014-12-31	$9,988
Participant contributions at beginning of year	2014-12-31	$20,220
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$2,782
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2014-12-31	$39,556
Other income not declared elsewhere	2014-12-31	$-652
Total non interest bearing cash at end of year	2014-12-31	$40,170
Total non interest bearing cash at beginning of year	2014-12-31	$12,256
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$1,368,131
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$15,910,267
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$14,542,136
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$12,172,025
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$10,975,820
Interest on participant loans	2014-12-31	$5,328
Value of interest in common/collective trusts at end of year	2014-12-31	$2,157,427
Value of interest in common/collective trusts at beginning of year	2014-12-31	$1,618,347
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2014-12-31	$664,242
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2014-12-31	$1,001,395
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2014-12-31	$1,001,395
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2014-12-31	$71
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$-231,098
Net investment gain or loss from common/collective trusts	2014-12-31	$114,130
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$823,763
Employer contributions (assets) at end of year	2014-12-31	$823,763
Employer contributions (assets) at beginning of year	2014-12-31	$799,225
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$877,084
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	BROCK AND COMPANY CPAS P.C.
Accountancy firm EIN	2014-12-31	840930288
2013 : WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$3,685,375
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$369,006
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$328,170
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$1,416,704
Value of total assets at end of year	2013-12-31	$14,542,136
Value of total assets at beginning of year	2013-12-31	$11,225,767
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$40,836
Total interest from all sources	2013-12-31	$6,192
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$501,423
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$501,423
Administrative expenses professional fees incurred	2013-12-31	$40,836
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$575,115
Participant contributions at end of year	2013-12-31	$114,873
Participant contributions at beginning of year	2013-12-31	$127,270
Participant contributions at end of year	2013-12-31	$20,220
Participant contributions at beginning of year	2013-12-31	$13,643
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$74,990
Other income not declared elsewhere	2013-12-31	$2,978
Liabilities. Value of operating payables at beginning of year	2013-12-31	$0
Total non interest bearing cash at end of year	2013-12-31	$12,256
Total non interest bearing cash at beginning of year	2013-12-31	$1,684
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$3,316,369
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$14,542,136
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$11,225,767
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$10,975,820
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$8,576,545
Interest on participant loans	2013-12-31	$6,096
Value of interest in common/collective trusts at end of year	2013-12-31	$1,618,347
Value of interest in common/collective trusts at beginning of year	2013-12-31	$1,113,046
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2013-12-31	$1,001,395
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2013-12-31	$797,631
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2013-12-31	$797,631
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2013-12-31	$96
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$1,519,693
Net investment gain or loss from common/collective trusts	2013-12-31	$238,385
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$766,599
Employer contributions (assets) at end of year	2013-12-31	$799,225
Employer contributions (assets) at beginning of year	2013-12-31	$595,948
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$328,170
Liabilities. Value of benefit claims payable at beginning of year	2013-12-31	$0
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	BROCK AND COMPANY CPAS P.C.
Accountancy firm EIN	2013-12-31	840930288
2012 : WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2012 401k financial data
Total unrealized appreciation/depreciation of assets	2012-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$106
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$7,092
Total income from all sources (including contributions)	2012-12-31	$2,322,708
Total loss/gain on sale of assets	2012-12-31	$0
Total of all expenses incurred	2012-12-31	$1,305,974
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$1,296,748
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$1,020,120
Value of total assets at end of year	2012-12-31	$11,193,141
Value of total assets at beginning of year	2012-12-31	$10,183,393
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$9,226
Total interest from all sources	2012-12-31	$5,892
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$251,258
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2012-12-31	$251,258
Administrative expenses professional fees incurred	2012-12-31	$9,117
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$450,438
Participant contributions at end of year	2012-12-31	$127,270
Participant contributions at beginning of year	2012-12-31	$145,602
Participant contributions at end of year	2012-12-31	$13,643
Participant contributions at beginning of year	2012-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$1,712
Other income not declared elsewhere	2012-12-31	$700
Liabilities. Value of operating payables at end of year	2012-12-31	$0
Liabilities. Value of operating payables at beginning of year	2012-12-31	$7,092
Total non interest bearing cash at end of year	2012-12-31	$1,684
Total non interest bearing cash at beginning of year	2012-12-31	$23,150
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$1,016,734
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$11,193,035
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$10,176,301
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Investment advisory and management fees	2012-12-31	$109
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$8,576,545
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$7,644,633
Interest on participant loans	2012-12-31	$5,892
Value of interest in common/collective trusts at end of year	2012-12-31	$1,113,046
Value of interest in common/collective trusts at beginning of year	2012-12-31	$942,102
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2012-12-31	$797,631
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2012-12-31	$801,558
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2012-12-31	$801,558
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2012-12-31	$76
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$1,045,438
Net investment gain or loss from common/collective trusts	2012-12-31	$135,189
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$567,970
Employer contributions (assets) at end of year	2012-12-31	$563,322
Employer contributions (assets) at beginning of year	2012-12-31	$626,348
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$1,296,748
Liabilities. Value of benefit claims payable at end of year	2012-12-31	$106
Liabilities. Value of benefit claims payable at beginning of year	2012-12-31	$0
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	BROCK AND COMPANY
Accountancy firm EIN	2012-12-31	840930288

Form 5500 Responses for WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST

2022: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: WESTERN NEPHROLOGY & METABOLIC BONE DISEASE, P.C. EMPLOYEE PS PLAN & TRUST 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	Yes
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	WESTERN NEPHROLOGY AND METABOLIC BONE DISEASE, P.C.
Employer identification number (EIN):	841460205
NAIC Classification:	621111
NAIC Description:	Offices of Physicians (except Mental Health Specialists)